Delivery Order SPE2DB20D7059-SPE2DB25FQFP3
- Not listed
- The Defense Logistics Agency awarded a $5,312.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Propranolol ER 160 mg capsules (100-count units) on July 11, 2025, with completion targeted for July 14, 2025. This non-competitive delivery order represents a direct fulfillment against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement (SPE2DX) that extends through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count) on August 6, 2025, with a ceiling value of $12,757.00 and completion date of August 7, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which is also the vendor's corporate headquarters location. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,258.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Propranolol ER 120 mg capsules (100-count units). This is a non-set-aside contract with a completion date of May 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) with a contract value of $6,630.72 and an ultimate completion date of July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Propranolol ER 80 mg capsules (1,000 count) valued at $1,122.92. This competitive award, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by September 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Propranolol ER 160 mg capsules in quantities of 100 units, with a contract ceiling value of $7,012.89. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency (DLA) awarded a $1,469.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of July 24, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) on September 17, 2025, with a ceiling value of $2,046.04 and an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 120 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,349.13. The award was made on April 25, 2025, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $3,785.24. This competitive award, issued May 6, 2025, with completion by May 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQFP3Delivery Order
The Defense Logistics Agency (DLA) awarded a $10,610.82 delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a broad portfolio of generic and brand-name medications to support military and veteran healthcare systems. The propranolol delivery under this order supports ongoing pharmaceutical needs across the Defense Health Agency and other federal healthcare customers. As a major pharmaceutical vendor with extensive experience fulfilling federal medical supply requirements through competitive procurement, AmerisourceBergen maintains the capacity to deliver diverse pharmaceutical products in quantities ranging from minimal orders to substantial high-value contracts, demonstrating its role as a key supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 5/2/25 |